The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
about
Risk factors for neoplastic progression in Barrett's esophagusSignaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingAbsolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancerMALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer.Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinomaRON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assayGastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasisNicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer MicroenvironmentTolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma.In silico dissection of miRNA targetome polymorphisms and their role in regulating miRNA-mediated gene expression in esophageal cancer.EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats.Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.Prognostic Value of C-met Expression in Cholangiocarcinoma.Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?TGFβ1 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesis.Neoplasia: An Anniversary of Progress.A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors.Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer.
P2860
Q27002062-0700FF47-190D-4115-A279-2F9615A355E9Q27026253-1AE1075D-FC96-477F-9DB1-AC047C1981DDQ28389391-1E9BD402-CEDA-4A1B-8FCF-527DCAAFE599Q28395095-9666C252-A828-4A71-AF81-D5AA65D1C303Q33830522-E3911097-A1B2-4C25-B6DB-F695F683AF7DQ33886974-A4618D1F-D2DA-47D4-B4CE-B61C1E9363FAQ34820809-A6E355EE-CF0A-4A72-9F1E-CEAE7B21EDE0Q35108386-496220EF-BFC6-42C1-8B5B-733AB35B1DDFQ35146597-B989219E-CBF1-45AB-9BF6-93A52055B477Q35666332-3BD9D432-0EA5-4D93-9FB1-AF75D477A366Q35830723-A1E122EE-1064-413E-B477-5C3BD680158FQ36205151-396F82A4-7CAC-4FC4-8B34-4568E8BC53C7Q36510119-49BFD4E7-CA8D-4306-A7D5-6C74489AC40FQ36713414-F9146D82-78C6-44A9-AC70-97768C99E612Q36759077-11F9B8FF-7801-4997-A42B-DAAEE260CAA2Q37246675-B378F815-2118-43C7-84D0-9A582366F1C4Q37522222-3E2DC443-C71E-4C9D-8C1D-2ACD0DB5D6F2Q38018063-C09E50EF-3071-436B-9E5B-940D409B0323Q38273489-5AB88255-6A52-456C-B756-3D161E09B82DQ38831897-2C051BC6-600F-47B0-82EA-FB24F7715C03Q39025928-36A6F3FE-F68D-429E-9EC9-301B8CB74291Q39613072-0078AB3E-0ED6-49E7-969C-BA3538C6EB94Q40203442-C5688F02-9687-4AFF-8F58-A3896CC6712BQ41073453-C3E7AA86-AE98-44A7-B838-06C46B72FBABQ41231601-EBA39F7E-DF0D-42C8-A925-A1CE677E8B91Q41832195-B4E40055-2A38-4489-AB60-9FAFF6CCA023Q46932476-0173DB38-B9CE-4D68-95CF-6E7688964DD5Q50958892-F8D801FD-CAA1-4E11-A4B6-328E50B2F000Q53711253-DB30BDE8-0AE7-4809-B139-80EDD8730D85
P2860
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@ast
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@en
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@nl
type
label
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@ast
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@en
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@nl
prefLabel
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@ast
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@en
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma
@en
P2093
James D Luketich
Luis J Herrera
Pierre E Queiroz de Oliveira
Steven J Hughes
Sydney Finkelstein
Talal El-Hefnawy
William Gooding
P2860
P356
10.1593/NEO.04367
P577
2005-01-01T00:00:00Z